Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden.
Sci Rep. 2023 Mar 1;13(1):3447. doi: 10.1038/s41598-023-30597-w.
There is limited data on long-term outcomes after hospitalization for ACS. We aimed to estimate the rate of recurrent cardiovascular events in the long-term, in a population-based, unselected cohort of ACS patients. We included 1379 patients with ACS hospitalized at Östersund hospital 2010-2014 and followed them from the day after discharge to 31 December 2017. The primary endpoint was the unadjusted rate of the composite of CV death, AMI and ischemic stroke. Risk factors for the primary endpoint were assessed in a multivariable Cox proportional hazards regression model. During a median follow-up of 4.7 years, the unadjusted rate of the primary endpoint was 10.3% at 1 year and 28.6% at the end of follow-up. Predictors of increased risk for subsequent events were congestive heart failure, diabetes mellitus, angina pectoris, prior revascularization with PCI or CABG and treatment with diuretics at discharge. Lipid-lowering therapy at discharge and revascularization with PCI or CABG were associated with a lower risk of recurrent events. The risk of recurrent cardiovascular was high at 1 year and continued to be so during the following almost 3 years of median follow-up. Established predictors of cardiovascular risk were confirmed.
关于 ACS 住院患者的长期结局数据有限。我们旨在评估在一个基于人群、未经选择的 ACS 患者队列中,长期内复发性心血管事件的发生率。我们纳入了 2010 年至 2014 年在厄斯特松德医院住院的 1379 例 ACS 患者,并在出院后第 1 天至 2017 年 12 月 31 日对其进行随访。主要终点是 CV 死亡、AMI 和缺血性卒中复合的未经调整发生率。在多变量 Cox 比例风险回归模型中评估了主要终点的危险因素。在中位随访 4.7 年期间,1 年时未调整的主要终点发生率为 10.3%,随访结束时为 28.6%。随后发生事件的风险增加的预测因素为充血性心力衰竭、糖尿病、心绞痛、既往经皮冠状动脉介入治疗或冠状动脉旁路移植术血运重建以及出院时使用利尿剂。出院时进行降脂治疗和经皮冠状动脉介入治疗或冠状动脉旁路移植术血运重建与复发性事件风险降低相关。1 年内复发性心血管风险较高,在随后的近 3 年中位随访期间仍如此。心血管风险的既定预测因素得到了证实。